ROS1 and breast cancer: Our study provided the identification of novel and rare pathogenic constitutive variants in ROS1 in hereditary BC, but the case study is relatively small; therefore, further studies in additional independent cohorts of familial BC cases is warranted to investigate the contribution of germline ROS1 variants to breast cancer predisposition.